Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FM
Subjects: NEOPLASIAS DO SISTEMA NERVOSO, GLIOMA (TERAPIA;DIAGNÓSTICO), CRIANÇAS
ABNT
EPELMA, S. et al. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf. Acesso em: 29 set. 2024. , 2015APA
Epelma, S., Odone, V., Gorender, E., Medeiros, R. S. S., & Silva, L. (2015). Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdfNLM
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 set. 29 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdfVancouver
Epelma S, Odone V, Gorender E, Medeiros RSS, Silva L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Pediatric Blood and Cancer. 2015 ; 62 S274.[citado 2024 set. 29 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/pbc.25715/epdf